Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-064210

Options or other derivatives

  • Director acquired 26,791 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MILLIGAN JOHN F Director 2024-05-21 Grant or award · Stock Option (Right To Buy) +26,791 26,791 D
Loading xslF345X05/ownership.xml…